Ms. Yoori Lee currently serves as Co-founder and President of Trio Health Advisory Group, Inc. Trio Health’s mission is to improve the quality of care in patient outcomes through coordinating the efforts of all patient care stakeholders. Its first-of-its-kind technology platform tracks patients throughout their journey giving pharmaceutical/biotechnology companies, specialty pharmacies, and physicians real-time access to information that simply does not exist anywhere else. Trio Health focuses on specialty disease states, such as hepatitis c, HIV, oncology, and cystic fibrosis, among others, and examines how each stakeholder impacts the performance of the patient. Trio Health has published extensively on real-world patients; publication topics have included: access to care, comparative effectiveness, physician & pharmacy performance, safety & tolerability, affordability between treatment regimens, and various other cohort analyses.
Prior to Trio Health, Ms. Lee spent over 15 years at Leerink Partners LLC, a leading healthcare investment bank, where she was Managing Director and Director of MEDACorp Services. Additionally, she helped found the MEDACorp network, a cadre of experts including more than 35,000 healthcare professionals in diverse areas of practice such as clinical medicine, biomedical research, regulatory affairs, public policy, healthcare administration, and healthcare information technology.